Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WA › MONROE › PUBLIC HOSPITAL DISTRICT 1 OF SNOHOMISH COUNTY

PUBLIC HOSPITAL DISTRICT 1 OF SNOHOMISH COUNTY

NPI: 1013074061 · MONROE, WA 98272 · General Acute Care Hospital · NPI assigned 01/02/2007

$11.26M
Total Medicaid Paid
325,304
Total Claims
266,440
Beneficiaries
181
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLAPLANTE, LISA (CHIEF ADMINISTRATIVE OFFICER)
NPI Enumeration Date01/02/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 45,161 $1.47M
2019 41,672 $1.30M
2020 35,490 $1.07M
2021 41,946 $1.25M
2022 54,911 $1.52M
2023 56,553 $2.10M
2024 49,571 $2.56M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
96361 Intravenous infusion, hydration; each additional hour 7,158 6,391 $1.85M
H0018 Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem 5,000 458 $1.54M
99284 Emergency department visit for the evaluation and management, high severity 13,084 12,021 $1.47M
99283 Emergency department visit for the evaluation and management, moderate severity 11,283 10,594 $1.37M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 11,571 10,568 $1.28M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,860 2,714 $682K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3,295 3,146 $327K
70450 Computed tomography, head or brain; without contrast material 2,242 2,102 $318K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 11,131 3,730 $249K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,604 1,453 $231K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3,067 2,730 $218K
80053 Comprehensive metabolic panel 17,694 14,705 $107K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 6,092 2,195 $106K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,463 1,337 $83K
74176 Computed tomography, abdomen and pelvis; without contrast material 418 397 $82K
71275 Computed tomographic angiography, chest, with contrast material 434 414 $78K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 22,365 17,956 $71K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1,302 898 $71K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 7,986 7,234 $57K
76705 Ultrasound, abdominal, real time with image documentation; limited 600 577 $55K
84484 7,405 5,487 $52K
G0378 Hospital observation service, per hour 807 636 $46K
96375 Therapeutic injection; each additional sequential IV push 7,229 6,416 $45K
97161 861 840 $38K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 8,455 7,563 $37K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3,042 2,588 $34K
84443 Thyroid stimulating hormone (TSH) 4,091 3,167 $32K
71045 Radiologic examination, chest; single view 4,182 3,878 $30K
71046 Radiologic examination, chest; 2 views 2,381 2,277 $30K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,570 4,281 $29K
36415 Collection of venous blood by venipuncture 14,591 11,264 $24K
83690 7,300 6,618 $24K
83605 4,018 3,443 $23K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 983 852 $23K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 141 126 $23K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 349 337 $23K
96164 1,169 202 $22K
83880 2,282 2,056 $22K
80048 Basic metabolic panel (calcium, ionized) 4,180 3,580 $21K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 118 64 $20K
96165 1,169 202 $20K
76830 Ultrasound, transvaginal 216 208 $19K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,150 916 $19K
80305 3,780 3,501 $17K
87086 Culture, bacterial; quantitative colony count, urine 4,222 3,960 $16K
83036 Hemoglobin; glycosylated (A1C) 2,589 1,765 $15K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 130 122 $15K
81001 11,446 10,463 $15K
70496 60 59 $14K
72125 Computed tomography, cervical spine; without contrast material 428 403 $13K
80061 Lipid panel 1,715 932 $12K
96376 2,211 2,022 $11K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 581 565 $10K
84703 2,625 2,482 $10K
87040 1,007 527 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,402 1,291 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 644 534 $8K
71260 Computed tomography, thorax, diagnostic; with contrast material 74 70 $7K
76801 148 129 $7K
82077 1,137 970 $7K
83735 3,910 3,151 $7K
70498 59 58 $7K
73610 362 346 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 594 555 $6K
90715 366 352 $6K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 24 24 $6K
84702 842 700 $6K
73630 330 318 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 581 565 $6K
85378 520 507 $5K
85610 2,658 2,206 $5K
87077 1,400 1,342 $5K
87186 1,245 1,182 $4K
J7050 Infusion, normal saline solution, 250 cc 1,307 853 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 660 641 $4K
81025 2,079 1,970 $4K
93971 41 38 $4K
J7120 Ringers lactate infusion, up to 1000 cc 1,912 1,532 $4K
82728 295 285 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,644 1,342 $3K
93975 27 24 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,944 4,441 $3K
J1170 Injection, hydromorphone, up to 4 mg 2,764 2,051 $3K
86803 253 242 $3K
73564 190 187 $3K
85027 436 425 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,731 5,697 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 312 298 $3K
J7030 Infusion, normal saline solution , 1000 cc 2,174 1,883 $3K
99232 Subsequent hospital care, per day, moderate complexity 102 69 $2K
J2270 Injection, morphine sulfate, up to 10 mg 2,943 2,489 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 394 380 $2K
73030 128 117 $2K
85379 458 443 $2K
12001 12 12 $2K
H0004 Behavioral health counseling and therapy, per 15 minutes 19 16 $2K
J0690 Injection, cefazolin sodium, 500 mg 682 541 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 440 405 $2K
80047 364 342 $2K
84439 275 252 $2K
77067 Screening mammography, bilateral, including computer-aided detection 26 25 $2K
86900 397 332 $1K
86901 564 492 $1K
J3010 Injection, fentanyl citrate, 0.1 mg 1,327 1,075 $1K
86850 347 327 $1K
86592 217 204 $1K
73130 77 77 $1K
73110 78 75 $1K
81003 806 774 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,571 1,499 $912.25
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 373 353 $904.57
J2060 Injection, lorazepam, 2 mg 1,580 1,357 $865.81
85730 1,056 979 $814.97
86140 236 220 $752.79
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,577 1,364 $738.52
77063 Screening digital breast tomosynthesis, bilateral 26 25 $692.86
99222 Initial hospital care, per day, moderate complexity 14 12 $672.39
82805 81 73 $637.70
82948 1,158 751 $637.13
82962 945 382 $609.95
87634 286 257 $604.48
85652 236 224 $594.99
99239 Hospital discharge day management, more than 30 minutes 14 12 $577.16
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 16 16 $561.37
96368 24 24 $556.89
J2250 Injection, midazolam hydrochloride, per 1 mg 897 840 $543.47
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 27 12 $508.95
J2765 Injection, metoclopramide hcl, up to 10 mg 1,137 1,042 $498.34
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 24 12 $475.14
0240U 572 558 $463.70
87070 92 86 $460.34
J3475 Injection, magnesium sulfate, per 500 mg 374 326 $425.18
97162 12 12 $386.08
85651 160 153 $378.97
80076 60 58 $346.74
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,921 1,821 $338.61
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 28 13 $315.51
72131 17 16 $304.11
82553 36 33 $292.39
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 287 267 $288.45
72128 13 12 $270.23
82565 327 314 $224.74
82550 150 137 $212.13
87075 27 25 $207.41
J2704 Injection, propofol, 10 mg 216 197 $199.84
80050 General health panel 31 29 $173.60
82803 63 60 $165.91
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 322 301 $161.33
87340 52 52 $144.41
87088 40 39 $142.64
87205 55 52 $124.41
83540 14 14 $117.95
83550 13 13 $115.64
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 40 40 $106.86
85014 93 89 $95.45
86780 15 15 $92.09
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 12 12 $88.37
86762 27 27 $83.99
85018 119 114 $78.53
J3370 Injection, vancomycin hcl, 500 mg 59 41 $73.26
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 15 12 $70.57
J0780 Injection, prochlorperazine, up to 10 mg 43 37 $64.76
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 31 30 $57.47
94760 279 248 $53.15
84100 47 36 $49.37
82248 27 27 $40.09
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 89 73 $36.55
J1171 Injection, hydromorphone, 0.1 mg 54 43 $33.82
A9270 Non-covered item or service 12,772 10,055 $22.47
82009 12 12 $22.14
J1650 Injection, enoxaparin sodium, 10 mg 26 13 $21.23
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 54 43 $17.42
36000 369 358 $17.07
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 659 576 $9.20
J1630 Injection, haloperidol, up to 5 mg 13 13 $6.60
A9575 Injection, gadoterate meglumine, 0.1 ml 28 27 $1.93
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 26 23 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 24 23 $0.00
94761 228 217 $0.00
87154 78 76 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 52 40 $0.00